Sorbent Therapeutics, Inc., is a private biopharmaceutical company focused on the development of oral, non-absorbed polymeric drugs to satisfy unmet needs in large cardio-renal markets, such as heart failure, chronic kidney disease and hypertension.

The array of customized compounds under development in our pipeline is based on Sorbent's proprietary, robust cross-linked polyelectrolyte (CLP) polymer technology. The CLP products are designed to manage serious, chronic conditions while passing through the GI tract unabsorbed, thus minimizing systemic exposure and potential side effects

Improving lives is our heart and soul